White House’s Covid coordinator urges people to get vaccinated ahead of holidays

White House’s Covid coordinator urges people to get vaccinated ahead of holidays


White House COVID-19 Response Coordinator Ashish Jha at the White House in Washington, October 25, 2022.

Jonathan Ernst | Reuters

As Covid and flu hospitalizations have climbed in the weeks since Thanksgiving, White House’s Covid-19 coordinator Dr. Ashish Jha said families will be safer at upcoming holiday gatherings if they get their updated vaccines.

This year, hospitals are facing the simultaneous threat of Covid, flu and RSV for the first time. Circulation of flu and RSV was very low during the pandemic due to widespread masking and social distancing implemented in response to Covid, but as most people return to normal life, all three viruses are circulating widely.

As of Dec. 14, the 7-day average of weekly new Covid cases reached 65,067, a 2.9% decrease from the previous week, according to CDC data.

“The good news here is that we can prevent those infections from turning into serious illness if people go out and get that updated bivalent vaccine,” Jha told ABC’s “This Week” Sunday.

Public health officials have said many people are probably more vulnerable to flu and RSV this year because they weren’t infected in the past two years, which means their immunity is lower. Around 23,503 patients were admitted to the hospital with influenza this week, the CDC reported, while RSV hospitalizations appear to have peaked in some states.

Hospitalizations of people with Covid topped more than 5,000 per day on average, according to the CDC.

“The updated vaccine is essential for keeping people out of the hospital,” Jha said. “So we’re making the case that we’re at a point where it’s safe to gather, but you still have things to do.”



Source

Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
Health

Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure

The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. President Donald Trump has been pressuring pharmaceutical companies to lower U.S. drug […]

Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Health

Trump’s pharmaceutical tariffs could affect some drugmakers more than others

Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]

Read More
Merck plans  billion cost cuts by end of 2027, narrows full-year outlook
Health

Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches […]

Read More